Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair

Laboratory Investigation

Volumn 89, Issue 2, 2009, Pages 131-141

  Antsiferova, Maria ^a   Klatte, Jennifer E ^b,c   Bodó, Enikö ^b   Paus, Ralf ^b,d   Jorcano, José L ^e   Matzuk, Martin M ^f   Werner, Sabine ^a   Kögel, Heidi ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF LÜBECK   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e CIEMAT   (Spain)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Activin; Dermis; Epidermis; Follistatin; Wound healing

Indexed keywords

ACTIVIN; FOLLISTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; EPIDERMIS CELL; EPITHELIUM; EPITHELIZATION; GRANULATION TISSUE; HAIR FOLLICLE; HOMEOSTASIS; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION; SKIN INJURY; TAIL; WOUND HEALING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BROMODEOXYURIDINE; CELL PROLIFERATION; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; EPIDERMIS; FEMALE; FOLLISTATIN; GENE EXPRESSION; GRANULATION TISSUE; HOMEOSTASIS; INHIBIN-BETA SUBUNITS; KERATINOCYTES; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOSTATIN; RNA, MESSENGER; WOUND HEALING;

EID: 59049092704     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.120     Document Type: Article

References (33)

1. Phillips DJ. The activin/inhibin family. In: Thomson AW, Lotze MT (eds). The Cytokine Handbook, 4th edn. Academic Press: London, 2003, pp 1153-1177.
2. Mathews LS. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev 1994;15:310-325.
3. Nakamura T, Takio K, Eto Y, et al. Activin-binding protein from rat ovary is follistatin. Science 1990;247:836-838.
4. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002;23:787-823.
5. Matzuk MM, Lu N, Vogel H, et al. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995;374:360-363.
6. Nakamura M, Matzuk MM, Gerstmayer B, et al. Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin. FASEB J 2003;17:497-499.
7. Lin SY, Craythorn RG, O'Connor AE, et al. Female infertility and disrupted angiogenesis are actions of specific follistatin isoforms. Mol Endocrinol 2008;22:415-429.
8. Werner S, Alzheimer C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev 2006;17:157-171.
9. Hubner G, Hu Q, Smola H, et al. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol 1996;173:490-498.
10. Wankell M, Munz B, Hubner G, et al. Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 2001;20:5361-5372.
11. Munz B, Smola H, Engelhardt F, et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 1999;18:5205-5215.
12. Ramirez A, Page A, Gandarillas A, et al. A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 2004;39:52-57.
13. Jorgez CJ, Klysik M, Jamin SP, et al. Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 2004;18:953-967.
14. Werner S, Smola H, Liao X, et al. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 1994;266:819-822.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
16. Werner S, Weinberg W, Liao X, et al. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J 1993;12:2635-2643.
17. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-386.
18. Montanez E, Piwko-Czuchra A, Bauer M, et al. Analysis of integrin functions in peri-implantation embryos, hematopoietic system, and skin. Methods Enzymol 2007;426:239-289.
19. Wankell M, Kaesler S, Zhang YQ, et al. The activin binding proteins follistatin and follistatin-related protein are differentially regulated in vitro and during cutaneous wound repair. J Endocrinol 2001;171:385-395.
20. de Winter JP, ten Dijke P, de Vries CJ, et al. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 1996;116:105-114.
21. Gamer LW, Wolfman NM, Celeste AJ, et al. A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev Biol 1999;208:222-232.
22. Iemura S, Yamamoto TS, Takagi C, et al. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 1998;95:9337-9342.
23. Amthor H, Nicholas G, McKinnell I, et al. Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol 2004;270:19-30.
24. Schneyer AL, Sidis Y, Gulati A, et al. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin. Endocrinology 2008;149:4589-4595.
25. Sidis Y, Mukherjee A, Keutmann H, et al. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 2006;147:3586-3597.
26. Otsuka F, Moore RK, Iemura S, et al. Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun 2001;289:961-966.
27. Bamberger C, Scharer A, Antsiferova M, et al. Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. Am J Pathol 2005;167:733-747.
28. Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature 2008;453:314-321.
29. Seishima M, Nojiri M, Esaki C, et al. Activin A induces terminal differentiation of cultured human keratinocytes. J Invest Dermatol 1999;112:432-436.
30. Sidis Y, Tortoriello DV, Holmes WE, et al. Follistatin-related protein and follistatin differentially neutralize endogenous vs exogenous activin. Endocrinology 2002;143:1613-1624.
31. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997;387:83-90.
32. Fumagalli M, Musso T, Vermi W, et al. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp Dermatol 2007;16:600-610.
33. Mukhopadhyay A, Chan SY, Lim IJ, et al. The role of the activin system in keloid pathogenesis. Am J Physiol Cell Physiol 2007;292:C1331-C1338.